Summary
This 8-K filing by Pfizer Inc. (PFE) on April 16, 2003, announces the definitive completion of its merger with Pharmacia Corporation. This significant event, effective as of April 16, 2003, marks the combination of operations between the two pharmaceutical giants. The merger was executed through a subsidiary, Pilsner Acquisition Sub Corp., which merged with Pharmacia, making Pharmacia a wholly-owned subsidiary of Pfizer. Under the terms of the merger, Pharmacia common stockholders received 1.4 shares of Pfizer common stock for each share of Pharmacia common stock they held. Additionally, Pharmacia preferred stockholders received equivalent preferred stock in Pfizer. This filing incorporates by reference key documents, including the merger agreement, joint proxy statement/prospectus, and the historical financial statements of Pharmacia Corporation, which will be crucial for understanding the combined entity's financial profile.
Key Highlights
- 1Pfizer Inc. has successfully completed its merger with Pharmacia Corporation, as of April 16, 2003.
- 2Pharmacia Corporation is now a wholly-owned subsidiary of Pfizer Inc. following the merger.
- 3Pharmacia common stockholders are set to receive 1.4 shares of Pfizer common stock per Pharmacia share.
- 4Pharmacia preferred stock will be converted into Pfizer preferred stock with equivalent rights.
- 5The merger agreement and related documents, including Pharmacia's historical financial statements, are incorporated by reference.
- 6Pro forma financial information for the combined entity will be filed by amendment on or before June 30, 2003.
- 7This transaction signifies a major consolidation within the pharmaceutical industry.